Pathos AI, which uses AI to develop oncology drugs, raised a $237M Series E at a $3B post-money valuation, up from a $1.6B valuation in May 2025 (Katherine Davis/Axios)

Katherine Davis / Axios:
Pathos AI, which uses AI to develop oncology drugs, raised a $237M Series E at a $3B post-money valuation, up from a $1.6B valuation in May 2025  —  Precision oncology biotech Pathos AI said Friday it raised a $237 million Series E round at a $3 billion post-money valuation.

原文：https://www.a8q9.cn/en/article/pathos-ai-which-uses-ai-to-develop-oncology-drugs-raised-a-237m-series-e-at-a-3b-e60646.html